Jianhua Wang
No. 127, Chang Le West Road
Xi'an, 710032, China
Xi'an, 710032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Therapeutic Evaluation of Induction Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma With Low-risk N Stage : A Multicenter Retrospective Study From Nonendemic Region of China.
Journal: American journal of clinical oncology
Published: March 07, 2023
Long-term survival outcomes and adverse effects of nasopharyngeal carcinoma patients treated with IMRT in a non-endemic region: a population-based retrospective study.
Journal: BMJ open
Published: August 03, 2021
Residual Volume of Lymph Nodes During Chemoradiotherapy Based Nomogram to Predict Survival of Nasopharyngeal Carcinoma Patient Receiving Induction Chemotherapy.
Journal: Frontiers in oncology
Published: July 10, 2021
Detailed analysis of recovery process of cranial nerve palsy after IMRT-based comprehensive treatment in nasopharyngeal carcinoma.
Journal: Radiation oncology (London, England)
Published: April 09, 2021
Gemcitabine and cisplatin versus docetaxel and cisplatin as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma from non-endemic area of China.
Journal: Journal of cancer research and clinical oncology
Published: February 26, 2020
Induction chemotherapy followed by concurrent chemoradiotherapy is benefit for advanced stage nasopharyngeal carcinoma with different nonkeratinizing carcinoma subtypes.
Journal: Scientific reports
Published: May 14, 2018
Induction chemotherapy for the treatment of non-endemic locally advanced nasopharyngeal carcinoma.
Journal: Oncotarget
Published: July 05, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026